Tenecteplase has similar safety to tissue plasminogen activator for acute ischemic stroke

For patients with acute ischemic stroke (AIS), tenecteplase (TNK) has improved functional outcome and reduced disability and similar safety to alteplase (tissue plasminogen activator [TPA]), according to a study published online Oct. 16 in Neurology.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup